|
|
Article: National Heart and Lung Institute, Faculty of Medicine describes research in asthma therapy.
- Article from:
- Biotech Week
- Article date:
- August 13, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Scientists discuss in 'Peroxisome proliferator-activated receptors as novel targets in lung disease' new findings in asthma. According to recent research published in the journal Chest, "Inflammatory diseases of the lung such as asthma and COPD represent a major worldwide health problem. There are potent antiinflammatory drugs available to treat asthma, such as the glucocorticoids, but these produce unwanted side effects and exhibit limited efficacy in the treatment of COPD."
"The identification of the peroxisome proliferator-activated receptors (PPARs) PPARgamma, PPARalpha, and PPARdelta opened up a new avenue of research as it was discovered that they exhibited ...
Related newspaper, magazine, and journal articles:
|
|
Article: New asthma therapy findings from Virginia ...
Biotech Week;
December 31, 2008 ;
700+ words
... ... research, 'Pharmacogenetic tests in asthma therapy,' is the subject of a report ... the United States report (see also Asthma Therapy). "Poor response may present as ... Medicine (Pharmacogenetic tests in asthma therapy. Clinics In Laboratory Medicine ...
|
|